References in periodicals archive ?
a company that manufactures skin care products containing epidermal growth factor and DNA repair enzymes.
Monoclonal antibodies to target epidermal growth factor receptor-positive tumors.
provides Epidermal Growth Factor market situation overview and supplies a list of Epidermal Growth Factor manufacturers and suppliers worldwide
Differential phosphorylation of mitogen-activated protein kinase families by epidermal growth factor and ultraviolet B irradiation in SV40-transformed human keratinocytes.
Epidermal Growth Factor Receptor (EGFR) inhibitors are currently used to treat non-small cell lung cancer, pancreatic, colorectal, and head & neck cancer.
The pollutant affects cellular receptors for epidermal growth factor (EGF), a hormonelike substance that contributes to development of many tissues.
Vectibix is the first entirely human monoclonal antibody for the treatment of patients with epidermal growth factor receptor- (EGFr) expressing metastatic colorectal cancer after disease progression on, or following fluoropyrimidine-, oxaliplatin-, and irinotecan- containing chemotherapy regimens.
These included the p53 protein--a known cancer fighter normally produced in response to the disease--and two others, Ki-67 and epidermal growth factor receptor (EGFR), that play a role in cell proliferation.
The protein acts as an epidermal growth factor (EGF), a peptide found in the salivary glands of many animals, Dyer says.
During the poster presentation session on June 5th, TMD presented data from their ongoing tdap(TM) study - Heterogeneity of Epidermal Growth Factor Receptor (EGFR) Expression and Variation in Immunohistochemistry (IHC) Testing May Affect Access to EGFR-Targeted Therapy in Patients with Advanced Colorectal Cancer (CRC).
They coated gold particles with rings of DNA containing either a piece of the gene for human epidermal growth factor or a marker gene.
Food and Drug Administration (FDA) has accepted the Biologic License Application (BLA) for panitumumab, an investigational fully human monoclonal antibody that targets the epidermal growth factor receptor (EGFr) and has granted Priority Review.

Full browser ?